Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
2011
Leucine-rich repeat kinase 2 and alpha-synuclein: pathways in Parkinson's disease
publication
Evidence: moderate
Author Information
Author(s): Greggio Elisa, Bisaglia Marco, Civiero Laura, Bubacco Luigi
Primary Institution: Department of Biology, University of Padova
Hypothesis
What are the experimental data supporting a common molecular pathway for dominant PD genes?
Conclusion
The study suggests that LRRK2 and alpha-synuclein may interact and influence each other's pathological roles in Parkinson's disease.
Supporting Evidence
- Mutations in LRRK2 are linked to both familial and sporadic forms of Parkinson's disease.
- Alpha-synuclein is a major component of Lewy bodies, which are characteristic of Parkinson's disease.
- Phosphorylation of alpha-synuclein may influence its aggregation and toxicity.
Takeaway
This study looks at two proteins, LRRK2 and alpha-synuclein, to see how they might work together to cause Parkinson's disease.
Methodology
The review discusses recent literature on LRRK2 and alpha-synuclein, focusing on their roles in Parkinson's disease.
Limitations
The review is based on existing literature and may not include all recent findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website